4/A//SEC Filing
Daniels Eric Joseph 4/A
Accession 0001104659-21-142530
CIK 0001372514other
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 4:31 PM ET
Size
5.1 KB
Accession
0001104659-21-142530
Insider Transaction Report
Form 4/AAmended
Daniels Eric Joseph
Chief Development Officer
Transactions
- Award
Common Stock
2021-10-21+9,520→ 9,520 total
Footnotes (2)
- [F1]These shares were omitted from the Reporting Person's Form 4 filed on November 10, 2021.
- [F2]Received by the Reporting Person in connection with the acquisition by the issuer of all of the outstanding securities of Bayon Therapeutics, Inc. on October 21, 2021.
Documents
Issuer
KIORA PHARMACEUTICALS INC
CIK 0001372514
Entity typeother
Related Parties
1- filerCIK 0001892943
Filing Metadata
- Form type
- 4/A
- Filed
- Nov 21, 7:00 PM ET
- Accepted
- Nov 22, 4:31 PM ET
- Size
- 5.1 KB